Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSCT with Cyclophosphamide, rATG, and Rituximab for SLE
NCT00278538Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Sep 2005
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, antithymocyte globulin rabbit, rituximab in systemic lupus erythematosus (SLE), sponsored by Northwestern University. Started Sep 2005; status: completed.
02
Drugs
cyclophosphamideantithymocyte globulin rabbitrituximab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00278538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278538.